Search results
Results from the WOW.Com Content Network
The MHRA has several independent advisory committees which provide the UK Government with information and guidance on the regulation of medicines and medical devices. There are currently eight such committees: [citation needed] Advisory Board on the Registration of Homeopathic Products; Herbal Medicines Advisory Committee; The Review Panel
The Retained EU Law (Revocation and Reform) Act 2023 (c. 28) is an act of the Parliament of the United Kingdom to revoke certain legislation implementing European Union law in the UK (retained EU law), following the UK's exit from the European Union.
The Independent Monitoring Authority for the Citizens' Rights Agreements (IMA; Welsh: Awdurdod Monitro Annibynnol ar gyfer y Cytundebau Hawliau Dinasyddion) [1] is a body corporate set up in the United Kingdom by the European Union (Withdrawal Agreement) Act 2020 [2] [3] to monitor the functioning of the provisions of the Brexit withdrawal agreement relating to citizens' rights, and to protect ...
Brexit delayed until 12 April: Mar 2019: Cooper–Letwin Act passed: Apr 2019: Brexit delayed until 31 October: Apr 2019: European Parliament election: May 2019: Theresa May resigns as PM: Jul 2019: Boris Johnson becomes PM: Jul 2019: Prorogation and annulment: Aug–Sep 2019: Benn Act passed: Sep 2019: Withdrawal agreement revised: Oct 2019 ...
Professor Sir Michael Rawlins, chair of the Medicines and Healthcare products Regulatory Agency (MHRA), the UK body that would take over from the European Medicines Agency, told the House of Lords in January 2017 that 'one of the biggest worries' he had about setting up a stand-alone regulator in post-Brexit Britain was that the UK would be 'at ...
Chequers—the official country residence of the prime minister since 1921—where the Brexit proposals were agreed by the Cabinet. The Chequers plan, officially known as The future relationship between the United Kingdom and the European Union (Cm 9593), was a UK Government white paper concerning Brexit, published on 12 July 2018 by the prime minister, Theresa May.
The Committee on the Future Relationship with the European Union, commonly known as the Brexit Select Committee and formerly the Exiting the European Union Select Committee, was a select committee of the British House of Commons that examines matters relating to the United Kingdom's relationship with the European Union after Brexit. [1]
The motion, which blocked a no-deal Brexit, was presented on 13 March. [94] [95] Two amendments to the motion were voted upon: the first, tabled by Caroline Spelman and categorically rejecting no-deal in any circumstances, passed 312–308; the second, the "Malthouse compromise" supporting a so-called "managed no-deal Brexit", failed 164–374.